The Pennant Group, Inc. (NASDAQ:PNTG - Get Free Report) has been given a consensus recommendation of "Moderate Buy" by the eight ratings firms that are presently covering the stock, MarketBeat Ratings reports. One investment analyst has rated the stock with a hold rating and seven have assigned a buy rating to the company. The average 12-month price objective among analysts that have issued ratings on the stock in the last year is $41.60.
Several equities research analysts recently issued reports on the stock. Royal Bank Of Canada raised their target price on shares of The Pennant Group from $42.00 to $44.00 and gave the stock an "outperform" rating in a report on Thursday, August 20th. Truist Financial raised their price target on The Pennant Group from $42.00 to $48.00 and gave the stock a "buy" rating in a research note on Tuesday, July 14th. Wells Fargo & Company upped their price objective on The Pennant Group from $45.00 to $46.00 and gave the company an "overweight" rating in a research report on Tuesday, August 11th. Weiss Ratings raised The Pennant Group from a "buy (b-)" rating to a "buy (b)" rating in a report on Wednesday, August 19th. Finally, Wall Street Zen raised The Pennant Group from a "hold" rating to a "buy" rating in a research report on Saturday, June 20th.
View Our Latest Research Report on PNTG
Hedge Funds Weigh In On The Pennant Group
A number of institutional investors and hedge funds have recently made changes to their positions in the business. Nykredit A S bought a new stake in The Pennant Group during the second quarter valued at approximately $29,000. Caitong International Asset Management Co. Ltd raised its position in The Pennant Group by 154.2% in the fourth quarter. Caitong International Asset Management Co. Ltd now owns 1,182 shares of the company's stock worth $33,000 after acquiring an additional 717 shares during the period. Parallel Advisors LLC raised its position in The Pennant Group by 1,186.8% in the first quarter. Parallel Advisors LLC now owns 1,364 shares of the company's stock worth $42,000 after acquiring an additional 1,258 shares during the period. GAMMA Investing LLC boosted its stake in shares of The Pennant Group by 34.6% during the 2nd quarter. GAMMA Investing LLC now owns 1,568 shares of the company's stock worth $58,000 after acquiring an additional 403 shares during the last quarter. Finally, Fifth Third Bancorp boosted its stake in shares of The Pennant Group by 548.9% during the 1st quarter. Fifth Third Bancorp now owns 6,807 shares of the company's stock worth $207,000 after acquiring an additional 5,758 shares during the last quarter. Hedge funds and other institutional investors own 85.88% of the company's stock.
The Pennant Group Price Performance
NASDAQ PNTG opened at $39.62 on Thursday. The Pennant Group has a one year low of $22.25 and a one year high of $42.74. The stock has a 50-day moving average of $39.21 and a 200 day moving average of $36.00. The company has a debt-to-equity ratio of 0.48, a quick ratio of 1.20 and a current ratio of 1.20. The company has a market capitalization of $1.38 billion, a price-to-earnings ratio of 44.02, a PEG ratio of 2.60 and a beta of 1.25.
The Pennant Group (NASDAQ:PNTG - Get Free Report) last announced its quarterly earnings results on Wednesday, August 5th. The company reported $0.36 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.33 by $0.03. The Pennant Group had a net margin of 2.93% and a return on equity of 10.33%. The firm had revenue of $297.98 million for the quarter, compared to the consensus estimate of $288.71 million. The Pennant Group has set its FY 2026 guidance at 1.340-1.410 EPS. On average, sell-side analysts forecast that The Pennant Group will post 1.18 EPS for the current year.
The Pennant Group Company Profile
(
Get Free Report)
The Pennant Group, Inc NASDAQ: PNTG is a healthcare services company that operates businesses focused on home-based care and senior living. Through its affiliated companies, Pennant provides home health, hospice and personal care services, as well as residential senior living services for older adults with varying care needs.
Its home health operations offer clinical care and rehabilitation services in patients' homes, while its hospice businesses provide comfort-focused care and support for individuals with advanced illnesses and their families.
See Also

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider The Pennant Group, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and The Pennant Group wasn't on the list.
While The Pennant Group currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
The AI boom is creating opportunities across semiconductors, cloud computing, enterprise software, infrastructure, cybersecurity, and automation.
Inside this report, you’ll find 10 companies positioned to benefit as artificial intelligence moves from hype to real-world deployment and becomes a core growth driver for corporate America.
Get This Free Report
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Like this article? Share it with a colleague.
Link copied to clipboard.